Splinting After Mini-Open Carpal Tunnel Release

August 25, 2016 updated by: Anthony L. Logli

A Prospective, Randomized Controlled Study of Splinting After Mini-Open Carpal Tunnel Release

The purpose of this study is to determine if any difference exists among 3 different postoperative splinting regimens- no splint, removable splint, and plaster non-removable splint- following mini-open carpal tunnel release (CTR) surgery.

Study Overview

Detailed Description

We sought to determine if any significant difference in patient-reported or clinical outcomes existed among 3 different postoperative splinting regimens- no splint, removable splint, and plaster non-removable splint- following mini-open carpal tunnel release (CTR) surgery for symptomatic, isolated, nerve conduction study positive carpal tunnel syndrome (CTS).

A total of 249 patients received a mini-open CTR and were subsequently randomized into 1 of the 3 splinting regimens to be removed at the first postoperative visit 10-14 days later. Patient-reported outcomes included QuickDASH surveys, Levine-Katz Symptom Severity Scale (SSS) and Functional Status Scale (FSS) and Pain at Rest and in Action using a Numerical Pain Rating Scale (NPRS). Clinical outcomes included wrist range of motion (ROM), grip and lateral pinch strengths. All outcomes were evaluated bilaterally at 10-14 days, 6 weeks, 3 months, 6 months and 12 months after surgery. Demographic information was obtained preoperatively and complications were observed for and recorded throughout the study

Study Type

Interventional

Enrollment (Actual)

249

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients were required to have failed conservative treatment for symptomatic, isolated, nerve conduction study positive CTS.

Exclusion Criteria:

  • Exclusion criteria omitted patients who presented with acute onset CTS, concomitant peripheral neuropathy, metabolic disease, postoperative recurring CTS, or who required another operative procedure during carpal tunnel release.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: No splint
The no splint group received a soft dressing consisting of an occlusive petroleum gauze strip (Xeroform, Mansfield, MA) over the wound, one folded 4x4 gauze, and a single wrap of roll gauze around the hand, and the wrist was placed and secured by a Coban wrap (3M, St. Paul, MN). The dressing permitted wrist and finger motion. Patients were further instructed to remove the dressing at five days and place an adhesive bandage (Band-Aid, Johnson & Johnson, New Brunswick, NJ) over the incision.
Experimental: Removable Splint
The removable splint group received a V-strap Wrist support (Medical Specialties, Inc., Charlotte, NC) placed over the identical soft dressing that was placed on the no splint group. The cock-up wrist splint was designed to keep the wrist fixed in a 20 degree extended wrist position. Patients were instructed to wear the splint for comfort as needed during day and night. While the patient was wearing the cock-up splint, only finger motion was permitted. Wrist motion was permitted when the cock-up splint was removed.
Experimental: Non-removable Splint
The plaster non-removable splint group received an occlusive petroleum gauze strip placed over the wound, followed by a 4X4 gauze, and a Webril cotton roll wrap (Covidien, Inc., Covidien, Ireland). A 4- inch, 15-layer thick plaster splint was placed across the volar wrist and molded to keep the wrist in approximately 20 degrees of extension allowing full digital range of motion (ROM). The splint was to be kept dry and not removed by the patient.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
QuickDASH
Time Frame: 10-14 days postoperatively
The Quick Disabilities of the Arm, Shoulder and Hand (DASH) Outcome Measure was designed in 1998 with the goal of providing a more accurate depiction of the everyday symptoms and handicaps exclusively experienced by a patient with an upper extremity musculoskeletal condition. Designed as a patient-completed questionnaire, the DASH Outcome Measure can be administered multiple times throughout patient care to measure changes in function and symptoms over time
10-14 days postoperatively
Levine-Katz Symptom Severity Scale (SSS)
Time Frame: 10-14 days postoperatively
The Levine-Katz Symptom Severity Scale (SSS) assesses pain, weakness, and sensation with 11 questions the patient rates on a 5-point scale with 5 indicating the most difficult; the average score is reported.
10-14 days postoperatively
Numerical Pain Rating Scale
Time Frame: 10-14 days postoperatively
Patients are asked to describe their level of pain intensity over the last 24 hours. The pain scale anchor points 0 and 10 correspond to no pain and worst imaginable pain, respectively. The NPRS can be used multiple times throughout patient care, but has the greatest value in describing post-operative pain-related morbidity.
10-14 days postoperatively
Grip Strength
Time Frame: 10-14 days postoperatively
Grip strength was taken with a Jamar Dynamometer in the 2nd hand position.
10-14 days postoperatively
Wrist Flexion
Time Frame: 10-14 days postoperatively
10-14 days postoperatively
Lateral Pinch Strength
Time Frame: 10-14 days postoperatively
Lateral pinch strength was taken with a Preston Pinch Gauge.
10-14 days postoperatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Demographic Information
Time Frame: Preoperatively
Sex, age, BMI, Smoking Status, Hand Dominance, Workers' Compensation Status
Preoperatively
Complications
Time Frame: 10-14 days postoperatively
Complications were observed for and recorded throughout the study.
10-14 days postoperatively

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
QuickDASH
Time Frame: 6 weeks postoperatively
The Quick Disabilities of the Arm, Shoulder and Hand (DASH) Outcome Measure was designed in 1998 with the goal of providing a more accurate depiction of the everyday symptoms and handicaps exclusively experienced by a patient with an upper extremity musculoskeletal condition. Designed as a patient-completed questionnaire, the DASH Outcome Measure can be administered multiple times throughout patient care to measure changes in function and symptoms over time
6 weeks postoperatively
QuickDASH
Time Frame: 3 months postoperatively
The Quick Disabilities of the Arm, Shoulder and Hand (DASH) Outcome Measure was designed in 1998 with the goal of providing a more accurate depiction of the everyday symptoms and handicaps exclusively experienced by a patient with an upper extremity musculoskeletal condition. Designed as a patient-completed questionnaire, the DASH Outcome Measure can be administered multiple times throughout patient care to measure changes in function and symptoms over time
3 months postoperatively
QuickDASH
Time Frame: 6 months postoperatively
The Quick Disabilities of the Arm, Shoulder and Hand (DASH) Outcome Measure was designed in 1998 with the goal of providing a more accurate depiction of the everyday symptoms and handicaps exclusively experienced by a patient with an upper extremity musculoskeletal condition. Designed as a patient-completed questionnaire, the DASH Outcome Measure can be administered multiple times throughout patient care to measure changes in function and symptoms over time
6 months postoperatively
QuickDASH
Time Frame: 12 months postoperatively
The Quick Disabilities of the Arm, Shoulder and Hand (DASH) Outcome Measure was designed in 1998 with the goal of providing a more accurate depiction of the everyday symptoms and handicaps exclusively experienced by a patient with an upper extremity musculoskeletal condition. Designed as a patient-completed questionnaire, the DASH Outcome Measure can be administered multiple times throughout patient care to measure changes in function and symptoms over time
12 months postoperatively
Levine-Katz Functional Status Scale (FSS)
Time Frame: 10-14 days postoperatively
The Levine-Katz Functional Status Scale (FSS) has 8 questions self-rated on a 5-point scale on difficulty with 5 meaning so difficult patient is unable to perform the function.
10-14 days postoperatively
Levine-Katz Functional Status Scale (FSS)
Time Frame: 6 weeks postoperatively
The Levine-Katz Functional Status Scale (FSS) has 8 questions self-rated on a 5-point scale on difficulty with 5 meaning so difficult patient is unable to perform the function.
6 weeks postoperatively
Levine-Katz Functional Status Scale (FSS)
Time Frame: 3 months postoperatively
The Levine-Katz Functional Status Scale (FSS) has 8 questions self-rated on a 5-point scale on difficulty with 5 meaning so difficult patient is unable to perform the function.
3 months postoperatively
Levine-Katz Functional Status Scale (FSS)
Time Frame: 6 months postoperatively
The Levine-Katz Functional Status Scale (FSS) has 8 questions self-rated on a 5-point scale on difficulty with 5 meaning so difficult patient is unable to perform the function.
6 months postoperatively
Levine-Katz Functional Status Scale (FSS)
Time Frame: 12 months postoperatively
The Levine-Katz Functional Status Scale (FSS) has 8 questions self-rated on a 5-point scale on difficulty with 5 meaning so difficult patient is unable to perform the function.
12 months postoperatively
Levine-Katz Symptom Severity Scale (SSS)
Time Frame: 6 weeks postoperatively
The Levine-Katz Symptom Severity Scale (SSS) assesses pain, weakness, and sensation with 11 questions the patient rates on a 5-point scale with 5 indicating the most difficult; the average score is reported.
6 weeks postoperatively
Levine-Katz Symptom Severity Scale (SSS)
Time Frame: 3 months postoperatively
The Levine-Katz Symptom Severity Scale (SSS) assesses pain, weakness, and sensation with 11 questions the patient rates on a 5-point scale with 5 indicating the most difficult; the average score is reported.
3 months postoperatively
Levine-Katz Symptom Severity Scale (SSS)
Time Frame: 6 months postoperatively
The Levine-Katz Symptom Severity Scale (SSS) assesses pain, weakness, and sensation with 11 questions the patient rates on a 5-point scale with 5 indicating the most difficult; the average score is reported.
6 months postoperatively
Levine-Katz Symptom Severity Scale (SSS)
Time Frame: 12 months postoperatively
The Levine-Katz Symptom Severity Scale (SSS) assesses pain, weakness, and sensation with 11 questions the patient rates on a 5-point scale with 5 indicating the most difficult; the average score is reported.
12 months postoperatively
Numerical Pain Rating Scale
Time Frame: 6 weeks postoperatively
Patients are asked to describe their level of pain intensity over the last 24 hours. The pain scale anchor points 0 and 10 correspond to no pain and worst imaginable pain, respectively. The NPRS can be used multiple times throughout patient care, but has the greatest value in describing post-operative pain-related morbidity.
6 weeks postoperatively
Numerical Pain Rating Scale
Time Frame: 3 months postoperatively
Patients are asked to describe their level of pain intensity over the last 24 hours. The pain scale anchor points 0 and 10 correspond to no pain and worst imaginable pain, respectively. The NPRS can be used multiple times throughout patient care, but has the greatest value in describing post-operative pain-related morbidity.
3 months postoperatively
Numerical Pain Rating Scale
Time Frame: 6 months postoperatively
Patients are asked to describe their level of pain intensity over the last 24 hours. The pain scale anchor points 0 and 10 correspond to no pain and worst imaginable pain, respectively. The NPRS can be used multiple times throughout patient care, but has the greatest value in describing post-operative pain-related morbidity.
6 months postoperatively
Numerical Pain Rating Scale
Time Frame: 12 months postoperatively
Patients are asked to describe their level of pain intensity over the last 24 hours. The pain scale anchor points 0 and 10 correspond to no pain and worst imaginable pain, respectively. The NPRS can be used multiple times throughout patient care, but has the greatest value in describing post-operative pain-related morbidity.
12 months postoperatively
Grip Strength
Time Frame: 6 weeks postoperatively
Grip strength was taken with a Jamar Dynamometer in the 2nd hand position.
6 weeks postoperatively
Grip Strength
Time Frame: 3 months postoperatively
Grip strength was taken with a Jamar Dynamometer in the 2nd hand position.
3 months postoperatively
Grip Strength
Time Frame: 6 months postoperatively
Grip strength was taken with a Jamar Dynamometer in the 2nd hand position.
6 months postoperatively
Grip Strength
Time Frame: 12 months postoperatively
Grip strength was taken with a Jamar Dynamometer in the 2nd hand position.
12 months postoperatively
Wrist Flexion
Time Frame: 6 weeks postoperatively
6 weeks postoperatively
Wrist Flexion
Time Frame: 3 months postoperatively
3 months postoperatively
Wrist Flexion
Time Frame: 6 months postoperatively
6 months postoperatively
Wrist Flexion
Time Frame: 12 months postoperatively
12 months postoperatively
Wrist Extension
Time Frame: 10-14 days postoperatively
10-14 days postoperatively
Wrist Extension
Time Frame: 6 weeks postoperatively
6 weeks postoperatively
Wrist Extension
Time Frame: 3 months postoperatively
3 months postoperatively
Wrist Extension
Time Frame: 6 months postoperatively
6 months postoperatively
Wrist Extension
Time Frame: 12 months postoperatively
12 months postoperatively
Lateral Pinch Strength
Time Frame: 6 weeks postoperatively
Lateral pinch strength was taken with a Preston Pinch Gauge.
6 weeks postoperatively
Lateral Pinch Strength
Time Frame: 3 months postoperatively
Lateral pinch strength was taken with a Preston Pinch Gauge.
3 months postoperatively
Lateral Pinch Strength
Time Frame: 6 months postoperatively
Lateral pinch strength was taken with a Preston Pinch Gauge.
6 months postoperatively
Lateral Pinch Strength
Time Frame: 12 months postoperatively
Lateral pinch strength was taken with a Preston Pinch Gauge.
12 months postoperatively
Complications
Time Frame: 6 weeks postoperatively
Complications were observed for and recorded throughout the study.
6 weeks postoperatively
Complications
Time Frame: 3 months postoperatively
Complications were observed for and recorded throughout the study.
3 months postoperatively
Complications
Time Frame: 6 months postoperatively
Complications were observed for and recorded throughout the study.
6 months postoperatively
Complications
Time Frame: 12 months postoperatively
Complications were observed for and recorded throughout the study.
12 months postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Brian J Bear, MD, OrthoIllinois

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2010

Primary Completion (Actual)

January 1, 2015

Study Completion (Actual)

January 1, 2015

Study Registration Dates

First Submitted

August 22, 2016

First Submitted That Met QC Criteria

August 25, 2016

First Posted (Estimate)

August 31, 2016

Study Record Updates

Last Update Posted (Estimate)

August 31, 2016

Last Update Submitted That Met QC Criteria

August 25, 2016

Last Verified

August 1, 2016

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Carpal Tunnel Syndrome

Clinical Trials on No Splint

3
Subscribe